Should you buy GPCR stock?
Last updated:
Based on market data through , StockInvest.us rates Structure Therapeutics Inc. (GPCR) as a Buy Candidate with a technical score of 3.53 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Buy signal since
- Price since signal Up 6.48%
- 3-month trend forecast Up 36.52%
- Lower volatility than the market (beta -1.57)
- +207.3% price growth over the last year
- Low bankruptcy risk (Altman Z-Score: 25.81)
Green day on Monday for Structure Therapeutics Inc.
(Market data through Aug 10, 2026)
The Structure Therapeutics Inc. stock price gained 1.25% on the last trading day (Monday, 10th Aug 2026), rising from $53.14 to $53.81. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 3.79% from a day low at $51.90 to a day high of $53.87. The price has risen in 7 of the last 10 days and is up by 10.51% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 30 thousand more shares were traded than the day before. In total, 358 thousand shares were bought and sold for approximately $19.29 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 36.52% during the next 3 months and, with a 90% probability hold a price between $67.56 and $86.24 at the end of this 3-month period.
GPCR Signals & Forecast
The Structure Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $50.88 and $50.44. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -4.99%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Structure Therapeutics Inc. stock
Structure Therapeutics Inc. finds support from accumulated volume at $52.12 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.97 between high and low, or 3.79%. For the last week, the stock has had daily average volatility of 5.07%.
Since the Structure Therapeutics Inc. has been rising for 6 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.
Our recommended stop-loss: $51.61 (-4.08%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 24 days ago.)
Trading Expectations (GPCR) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Structure Therapeutics Inc. to open at $53.19, and during the day (based on 14 day Average True Range), to move between $52.52 and $55.09, which gives a possible trading interval of +/-$2.56 (+/-4.88%) up or down from last closing price. If Structure Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 4.88% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $54.75 (1.76%) than the support at $52.12 (3.13%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Structure Therapeutics Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Structure Therapeutics Inc. stock to perform well in the short-term.
Current score:
3.530
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $53.19 ( 1.14%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
GPCR Performance
Trading levels for GPCR
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 55.16 | 2.52% |
| R2 | 54.41 | 1.12% |
| R1 | 53.94 | 0.257% |
| Price | 53.81 | |
| S1 | 52.44 | -2.54% |
| S2 | 51.97 | -3.40% |
| S3 | 51.22 | -4.80% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 56.63 | 5.25% |
| R2 | 54.89 | 2.02% |
| R1 | 54.75 | 1.76% |
| Price | 53.81 | |
| S1 | 52.12 | -3.13% |
| S2 | 45.61 | -15.23% |
| S3 | 41.25 | -23.33% |
FAQ
Click here for our free guide on how to buy Structure Therapeutics Inc. Stock.
Buy GPCR